Oxford Covid Vaccine
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
-
www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
www.ndtv.com
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
- Wednesday August 11, 2021
- World News | Press Trust of India
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
-
www.ndtv.com
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
- Friday July 23, 2021
- World News | Janice Kew, Bloomberg
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
www.ndtv.com
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
- Sunday June 27, 2021
- World News | Agence France-Presse
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
www.ndtv.com
-
How to Download COVID-19 Vaccine Certificate
- Friday May 14, 2021
- Tasneem Akolawala
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
www.gadgets360.com
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
- Thursday April 22, 2021
- India News | Press Trust of India
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
www.ndtv.com
-
Italy To Restart AstraZeneca Vaccinations From Friday, Says PM
- Thursday March 18, 2021
- World News | Agence France-Presse
Italy will resume administering AstraZeneca/Oxford coronavirus vaccines on Friday after the EU's drugs regulator declared them safe, Prime Minister Mario Draghi said.
-
www.ndtv.com
-
Germany To Recommend Oxford Covid Vaccine For Over 65s: Angela Merkel
- Thursday March 4, 2021
- World News | Agence France-Presse
Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.
-
www.ndtv.com
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
-
www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
www.ndtv.com
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
- Wednesday August 11, 2021
- World News | Press Trust of India
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
-
www.ndtv.com
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
- Friday July 23, 2021
- World News | Janice Kew, Bloomberg
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
www.ndtv.com
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
- Sunday June 27, 2021
- World News | Agence France-Presse
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
www.ndtv.com
-
How to Download COVID-19 Vaccine Certificate
- Friday May 14, 2021
- Tasneem Akolawala
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
www.gadgets360.com
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
- Thursday April 22, 2021
- India News | Press Trust of India
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
www.ndtv.com
-
Italy To Restart AstraZeneca Vaccinations From Friday, Says PM
- Thursday March 18, 2021
- World News | Agence France-Presse
Italy will resume administering AstraZeneca/Oxford coronavirus vaccines on Friday after the EU's drugs regulator declared them safe, Prime Minister Mario Draghi said.
-
www.ndtv.com
-
Germany To Recommend Oxford Covid Vaccine For Over 65s: Angela Merkel
- Thursday March 4, 2021
- World News | Agence France-Presse
Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.
-
www.ndtv.com